These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 15499998)

  • 21. Carbonic anhydrase inhibitory properties of novel benzylsulfamides using molecular modeling and experimental studies.
    Göksu S; Naderi A; Akbaba Y; Kalın P; Akıncıoğlu A; Gülçin İ; Durdagi S; Salmas RE
    Bioorg Chem; 2014 Oct; 56():75-82. PubMed ID: 25159522
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Carbonic anhydrase inhibitors: copper(II) complexes of polyamino-polycarboxylamido aromatic/heterocyclic sulfonamides are very potent inhibitors of the tumor-associated isoforms IX and XII.
    Rami M; Winum JY; Innocenti A; Montero JL; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2008 Jan; 18(2):836-41. PubMed ID: 18042384
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and carbonic anhydrase isoenzymes I and II inhibitory effects of novel benzylamine derivatives.
    Çetinkaya Y; Göçer H; Göksu S; Gülçin İ
    J Enzyme Inhib Med Chem; 2014 Apr; 29(2):168-74. PubMed ID: 23391138
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Carbonic anhydrase inhibitors. Inhibition of cytosolic isozymes I and II and transmembrane, cancer-associated isozyme IX with lipophilic sulfonamides.
    Franchi M; Vullo D; Gallori E; Pastorek J; Russo A; Scozzafava A; Pastorekova S; Supuran CT
    J Enzyme Inhib Med Chem; 2003 Aug; 18(4):333-8. PubMed ID: 14567548
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and carbonic anhydrase I, II, VII, and IX inhibition studies with a series of benzo[d]thiazole-5- and 6-sulfonamides.
    Abdoli M; Angeli A; Bozdag M; Carta F; Kakanejadifard A; Saeidian H; Supuran CT
    J Enzyme Inhib Med Chem; 2017 Dec; 32(1):1071-1078. PubMed ID: 28753093
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis of 4-sulfamoylphenyl-benzylamine derivatives with inhibitory activity against human carbonic anhydrase isoforms I, II, IX and XII.
    Durgun M; Turkmen H; Ceruso M; Supuran CT
    Bioorg Med Chem; 2016 Mar; 24(5):982-8. PubMed ID: 26803577
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel Re(I) tricarbonyl coordination compounds based on 2-pyridyl-1,2,3-triazole derivatives bearing a 4-amino-substituted benzenesulfonamide arm: synthesis, crystal structure, computational studies and inhibitory activity against carbonic anhydrase I, II, and IX isoforms†.
    Aimene Y; Eychenne R; Mallet-Ladeira S; Saffon N; Winum JY; Nocentini A; Supuran CT; Benoist E; Seridi A
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):773-782. PubMed ID: 30843736
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Carbonic anhydrase inhibitors: metal complexes of a sulfanilamide derived Schiff base and their interaction with isozymes I, II and IV.
    Ul-Hassan M; Scozzafava A; Chohan ZH; Supuran CT
    J Enzyme Inhib; 2001 Dec; 16(6):499-505. PubMed ID: 12164389
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis of Schiff base derivatives of 4-(2-aminoethyl)-benzenesulfonamide with inhibitory activity against carbonic anhydrase isoforms I, II, IX and XII.
    Durgun M; Turkmen H; Ceruso M; Supuran CT
    Bioorg Med Chem Lett; 2015 Jun; 25(11):2377-81. PubMed ID: 25913118
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sulfonamides incorporating 1,3,5-triazine moieties selectively and potently inhibit carbonic anhydrase transmembrane isoforms IX, XII and XIV over cytosolic isoforms I and II: Solution and X-ray crystallographic studies.
    Carta F; Garaj V; Maresca A; Wagner J; Avvaru BS; Robbins AH; Scozzafava A; McKenna R; Supuran CT
    Bioorg Med Chem; 2011 May; 19(10):3105-19. PubMed ID: 21515057
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of the α-carbonic anhydrase from Vibrio cholerae with amides and sulfonamides incorporating imidazole moieties.
    De Vita D; Angeli A; Pandolfi F; Bortolami M; Costi R; Di Santo R; Suffredini E; Ceruso M; Del Prete S; Capasso C; Scipione L; Supuran CT
    J Enzyme Inhib Med Chem; 2017 Dec; 32(1):798-804. PubMed ID: 28569564
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro inhibition of α-carbonic anhydrase isozymes by some phenolic compounds.
    Oztürk Sarikaya SB; Topal F; Sentürk M; Gülçin I; Supuran CT
    Bioorg Med Chem Lett; 2011 Jul; 21(14):4259-62. PubMed ID: 21669522
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides incorporating 1,2,4-triazine moieties.
    Garaj V; Puccetti L; Fasolis G; Winum JY; Montero JL; Scozzafava A; Vullo D; Innocenti A; Supuran CT
    Bioorg Med Chem Lett; 2004 Nov; 14(21):5427-33. PubMed ID: 15454239
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Carbonic anhydrase inhibitors: inhibition of the human isozymes I, II, VA, and IX with a library of substituted difluoromethanesulfonamides.
    Cecchi A; Taylor SD; Liu Y; Hill B; Vullo D; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2005 Dec; 15(23):5192-6. PubMed ID: 16203142
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Carbonic anhydrase inhibitors: Synthesis and inhibition of the cytosolic mammalian carbonic anhydrase isoforms I, II and VII with benzene sulfonamides incorporating 4,5,6,7-tetrachlorophthalimide moiety.
    Sethi KK; Verma SM; Tanç M; Carta F; Supuran CT
    Bioorg Med Chem; 2013 Sep; 21(17):5168-74. PubMed ID: 23867389
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pyridazinone substituted benzenesulfonamides as potent carbonic anhydrase inhibitors.
    Yaseen R; Ekinci D; Senturk M; Hameed AD; Ovais S; Rathore P; Samim M; Javed K; Supuran CT
    Bioorg Med Chem Lett; 2016 Feb; 26(4):1337-41. PubMed ID: 26804228
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel 2-substituted-benzimidazole-6-sulfonamides as carbonic anhydrase inhibitors: synthesis, biological evaluation against isoforms I, II, IX and XII and molecular docking studies.
    Milite C; Amendola G; Nocentini A; Bua S; Cipriano A; Barresi E; Feoli A; Novellino E; Da Settimo F; Supuran CT; Castellano S; Cosconati S; Taliani S
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):1697-1710. PubMed ID: 31537132
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides incorporating thioureido-sulfanilyl scaffolds.
    Puccetti L; Fasolis G; Cecchi A; Winum JY; Gamberi A; Montero JL; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2005 May; 15(9):2359-64. PubMed ID: 15837325
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and comparative carbonic anhydrase inhibition of new Schiff's bases incorporating benzenesulfonamide, methanesulfonamide, and methylsulfonylbenzene scaffolds.
    El-Azab AS; Abdel-Aziz AA; Bua S; Nocentini A; Alanazi MM; AlSaif NA; Al-Suwaidan IA; Hefnawy MM; Supuran CT
    Bioorg Chem; 2019 Nov; 92():103225. PubMed ID: 31493707
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Carbonic anhydrase inhibitors: X-ray crystal structure of a benzenesulfonamide strong CA II and CA IX inhibitor bearing a pentafluorophenylaminothioureido tail in complex with isozyme II.
    Di Fiore A; De Simone G; Menchise V; Pedone C; Casini A; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2005 Apr; 15(7):1937-42. PubMed ID: 15780637
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.